Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.5151
-0.0275 (-5.07%)
At close: May 15, 2026, 4:00 PM EDT
0.5199
+0.0048 (0.93%)
Pre-market: May 18, 2026, 7:00 AM EDT
Werewolf Therapeutics Employees
Werewolf Therapeutics had 39 employees as of December 31, 2025. The number of employees decreased by 7 or -15.22% compared to the previous year.
Employees
39
Change
-7
Growth
-15.22%
Revenue / Employee
n/a
Profits / Employee
-$1,442,692
Market Cap
25.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | -7 | -15.22% |
| Sep 30, 2025 | 39 | -6 | -13.33% |
| Jun 30, 2025 | 46 | 1 | 2.22% |
| Mar 31, 2025 | 46 | 0 | - |
| Dec 31, 2024 | 46 | -1 | -2.13% |
| Sep 30, 2024 | 45 | -1 | -2.17% |
| Jun 30, 2024 | 45 | -3 | -6.25% |
| Mar 31, 2024 | 46 | 0 | - |
| Dec 31, 2023 | 47 | 1 | 2.17% |
| Sep 30, 2023 | 46 | -2 | -4.17% |
| Jun 30, 2023 | 48 | 1 | 2.13% |
| Mar 31, 2023 | 46 | 4 | 9.52% |
| Dec 31, 2022 | 46 | 7 | 17.95% |
| Sep 30, 2022 | 48 | 12 | 33.33% |
| Jun 30, 2022 | 47 | 16 | 51.61% |
| Mar 31, 2022 | 42 | 14 | 50.00% |
| Dec 31, 2021 | 39 | 15 | 62.50% |
| Sep 30, 2021 | 36 | 12 | 50.00% |
| Jun 30, 2021 | 31 | - | - |
| Mar 31, 2021 | 28 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 123 |
| Vistagen Therapeutics | 59 |
| Palatin Technologies | 29 |
| Jasper Therapeutics | 22 |
| Outlook Therapeutics | 17 |
| Serina Therapeutics | 13 |
| Neuphoria Therapeutics | 8 |
| Dyadic International | 6 |
HOWL News
- 10 days ago - Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 7 weeks ago - Werewolf Therapeutics hires Piper Sandler to assist in strategic evaluation - TheFly
- 7 weeks ago - Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c) - TheFly
- 7 weeks ago - Werewolf Therapeutics to explore range of strategic alternatives - TheFly
- 7 weeks ago - Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 2 months ago - Werewolf Therapeutics to explore strategic alternatives - TheFly
- 2 months ago - Werewolf Therapeutics trading resumes - TheFly
- 2 months ago - Werewolf Therapeutics trading halted, news pending - TheFly